Deferasirox (Exjade) significantly improves cardiac T2* in heavily iron-overloaded patients with beta-thalassemia major.
about
Deferasirox for managing iron overload in people with thalassaemiaLiver iron content determination by magnetic resonance imaging.Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging.Comparative efficacy and safety of deferoxamine, deferiprone and deferasirox on severe thalassemia: a meta-analysis of 16 randomized controlled trials.Management of transfusional iron overload - differential properties and efficacy of iron chelating agents.Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overloadComparative effects of three iron chelation therapies on the quality of life of greek patients with homozygous transfusion-dependent Beta-thalassemia.International survey of T2* cardiovascular magnetic resonance in β-thalassemia majorAustralian guidelines for the assessment of iron overload and iron chelation in transfusion-dependent thalassaemia major, sickle cell disease and other congenital anaemias.Iron chelation therapy in the management of transfusion-related cardiac iron overload.Deferasirox: a review of its use for chronic iron overload in patients with non-transfusion-dependent thalassaemia.Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study).Sustained improvements in myocardial T2* over 2 years in severely iron-overloaded patients with beta thalassemia major treated with deferasirox or deferoxamine.Deferasirox for managing iron overload in people with thalassaemia.Comparison of iron chelation effects of deferoxamine, deferasirox, and combination of deferoxamine and deferiprone on liver and cardiac T2* MRI in thalassemia maior.The role of magnetic resonance imaging in the evaluation of transfusional iron overload in myelodysplastic syndromesUpdate on the use of deferasirox in the management of iron overload.Iron chelation therapy in thalassemia syndromesTherapeutic value of combined therapy with deferasirox and silymarin on iron overload in children with Beta thalassemia.Cost-utility analysis of oral deferasirox versus infusional deferoxamine in transfusion-dependent β-thalassemia patients.Effect of iron overload on impaired fertility in male patients with transfusion-dependent beta-thalassemia.
P2860
Q24203718-C8E2C504-AC10-4298-9CF7-ADC31040C70FQ33764777-56BFD2F7-2A1D-437F-9769-8233A3FF5563Q34451519-8553C59C-5762-4A7D-87CA-87D973786FC3Q35077670-E88EAA9E-C24B-49EC-B06C-65B28A294ABEQ35683841-1B54F6FD-6BF1-4595-8D6B-A5D442136B57Q35813192-BFE0C9AE-6675-4156-B4E9-994FBB8EA093Q36500199-711656E1-40E1-49B2-8B2C-BAE8CA0B58FDQ37144860-81FD263E-85E8-42CD-90E1-94D320EC176EQ37880227-63ADA03F-60AB-432A-A6C7-830512F46F22Q37992181-84A6A697-1BAB-41AF-B6D2-B05BEBD9E030Q38219588-DDD1374A-1580-4988-85C4-D99AE1622B3EQ38388734-DDAAA362-DCD5-48D8-87B7-08F3EF612736Q38421726-BE2DAE12-EBB5-4660-9205-07770F463FB8Q38624033-D57A6BB3-C142-424B-9457-3D10308EFCC3Q41187475-98001064-7998-4C59-929C-7F74CD973996Q41856578-31D85E97-64BB-44D0-AE7E-A06F947158A0Q42117340-55DBF0DC-6340-4D7D-BEC8-0B0B4999CF60Q42588949-05D768C6-B7C4-488B-B103-BDFF1893F6DEQ42787159-4F810A64-5CF9-40E4-9D61-5EF011BD5FE6Q46103118-D007123D-C5BA-4EC6-9B56-907AA78E28C3Q49796274-0ACA8F30-2E24-4521-9FDE-4E294665796D
P2860
Deferasirox (Exjade) significantly improves cardiac T2* in heavily iron-overloaded patients with beta-thalassemia major.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Deferasirox (Exjade) significa ...... s with beta-thalassemia major.
@ast
Deferasirox (Exjade) significa ...... s with beta-thalassemia major.
@en
type
label
Deferasirox (Exjade) significa ...... s with beta-thalassemia major.
@ast
Deferasirox (Exjade) significa ...... s with beta-thalassemia major.
@en
prefLabel
Deferasirox (Exjade) significa ...... s with beta-thalassemia major.
@ast
Deferasirox (Exjade) significa ...... s with beta-thalassemia major.
@en
P2860
P1433
P1476
Deferasirox (Exjade) significa ...... s with beta-thalassemia major.
@en
P2093
Shahina Daar
P2860
P304
P356
10.1007/S00277-009-0838-Z
P577
2009-10-02T00:00:00Z